CIK: 1979548 - Address: 8755 W. Higgins Road, Suite 1025, Chicago, IL 60631
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/29/25 19:21
10/27/25
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP5,0002.6101,916633,848I
8/1/25 19:19
8/1/25
PRMEPrime Medicine, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP10,0003.3003,0302018,487I
2/3/25 19:01
2/3/25
MTSRMetsera, Inc.DEHealthDrugPharmaceutical PreparationsArch Venture Partners Xii, LLCILTP.d40,00018.0002,222368,314I
2/20/24 17:38
2/15/24
PRMEPrime Medicine, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP20,0006.2503,2002615,457I
11/15/23 18:54
11/13/23
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP.m41211.7703514,131I
11/13/23 19:00
11/8/23
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP.m1,54410.98014144,096I
11/7/23 18:59
11/3/23
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP.m1,10011.4909623,956I
9/29/23 18:53
9/28/23
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP.m1,04713.6807723,860I
9/27/23 20:18
9/26/23
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP.m70011.9705923,783I
9/25/23 21:38
9/22/23
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagArch Venture Partners Xii, LLCILTP.m1,12711.19010133,725I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact